Истраживачи
Jelić, Svetislav
Godina
Rezultati 61-75 od 75
| Година | Наслов | Аутор(и) | Тип резултата | Мп-кат. |
|---|---|---|---|---|
| 2005 | Incomplete liver resection plus chemotherapy in patients with metastatic colorectal cancer (CRC) decrease survival in comparison to chemotherapy alone | Popov, Ivan | Conference Paper | Mp. category will be shown later |
| 2005 | Lower than standard doses of irinotecan (cpt-11) in the treatment of metastatic colorectal carcinoma (MCC) | Nikolić-Tomašević, Zorica | Conference Paper | Mp. category will be shown later |
| 2005 | ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of soft tissue sarcomas | Leyvraz, S.; Jelić, Svetislav | Article | 21M21 |
| 2005 | Patterns of toxicity in elderly with locoregionally advanced squamocellular head and neck carcinomas treated with enhanced neoadjuvant chemotherapy | Kreačić, Miroslav | Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2005 | Cisplatin or carboplatin-based regimens for small-cell lung cancer - a randomized phase III study | Jezdić, Svetlana | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2005 | A Simon 2 stage study of 5,10 methylenetetrahydrofolic acid (CO) with 5-fluorouracil (FU) as first line treatment in metastatic colorectal cancer (mCRC) | Reid, T. R.; Spears, C. P.; Quadro, R.; Subramanian, M.; Pawl, L.; Janković, Gradimir; Jelić, Svetislav | Conference Paper | Mp. category will be shown later |
| 2005 | ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of squamous cell carcinoma of the head and neck (SCCHN) | Pivot, X.; Kataja, V. V.; Jelić, Svetislav | Article | 21M21 |
| 2005 | Prognostic importance of objective response (OR) to chemotherapy for time to progression (TTP) and survival time (ST) in advanced non-small cell lung cancer (NSCLC) - analysis of individual patient data from platinum-based clinical trials in monocentric setting | Radosavljević, Davorin; Jelić, Svetislav | Conference Paper | Mp. category will be shown later |
| 2005 | Clinical factors that influence the hazard of death in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy - analysis of individual patient data from prospective trials in monocentric setting | Radosavljević, Davorin; Kezić, Iva; Jelić, Svetislav | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2005 | ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant glioma | Stupp, R.; Pavlidis, N.; Jelić, Svetislav | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 |
| 2005 | Events associated with decision for first-line chemotherapy withdrawal in patients with small-cell lung cancer (SCLC) | Jelić, Svetislav | Конференцијски рад | Мп категорија ће бити приказана накнадно. |
| 2004 | What patients want to know about disease and treatment | Nikolić-Tomašević, Zorica | Conference Paper | Mp. category will be shown later |
| 2004 | Capecitabine (X) is resource saving compared with i.v. bolus 5-FU/LV in adjuvant chemotherapy for Dukes' C colon cancer patients - medical resource utilization (MRU) data from a large phase III trial (X-ACT) | McKendrick, J. J.; Cassidy, J.; Chakrapee-Sirisuk, S.; Fountzilas, G.; Iveson, T.; Jelić, Svetislav | Conference Paper | Mp. category will be shown later |
| 2004 | Etika naučnoistraživačkog rada u biomedicini![]() | Bogdanović, Gordana; Vučković-Dekić, Ljiljana | Monografija | Mp kategorija će biti prikazana naknadno. |
| 1997 | Assessment of early epirubicin cardiotoxicity in women with breast cancer![]() | Šobić-Šaranović, Dragana | Научни чланак | 22M22 - Међународни часопис категорије M22 |
